Thomas Forissier, principal for the life sciences practice of Capgemini Consulting, discusses insights from Capgemini’s latest Vision and Reality report
As regulatory hurdles mount and product pipelines shrivel, pharma companies must seek new revenue drivers to maintain growth.
Addressing patient adherence, and thereby improving health outcomes and increasing potential revenue, is a popular answer to the problem.
And yet improving patient adherence is a vexing task.
The key influencers and root causes of non-adherence have proved as hard to pinpoint as the solutions for the recurring behavior.
In this podcast, Thomas Forissier, principal for the life sciences practice of Capgemini Consulting, discusses Capgemini’s latest Vision and Reality report, “Patient Adherence: The Next Frontier in Patient Care.”
Specifically, he explores the difficulties of addressing non-adherence for all stakeholders and the importance of pharma companies finding solutions.
For additional strategies on improving patient adherence, download Capgemini Consulting’s research report, Patient Adherence: The Next Frontier in Patient Care, or connect with us at eyeforpharma’s PACE 2011 event on October 24-25.
For everything patient-related, join the sector’s other key players at Patient Adherence, Communication and Engagement (PACE) USA on October 24-25 in Philadelphia. Download the full PACE agenda and speaker line-up here. Want to know more? Contact email@example.com.
To read our Patients’ Week stories from 2010, see Patients’ Week 2010.
For all the latest business analysis and insight for the pharma industry, sign up to eyeforpharma’s newsletters.
The Yale University Open Data project (YODA) have been given total access to all patient-level data...
“Our primary focus is the on-going evolution of the delivery of our customer-facing operating model...
New partnership between PatientsLikeMe and inVentiv Health demonstrates the expanding role of...